IVECO GROUP NV (IVG.MI) Stock Fundamental Analysis

BIT:IVG • NL0015000LU4

18.875 EUR
+0.02 (+0.13%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

IVG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 109 industry peers in the Machinery industry. IVG has a medium profitability rating, but doesn't score so well on its financial health evaluation. IVG has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year IVG was profitable.
  • IVG had a positive operating cash flow in the past year.
  • IVG had positive earnings in 4 of the past 5 years.
  • IVG had a positive operating cash flow in each of the past 5 years.
IVG.MI Yearly Net Income VS EBIT VS OCF VS FCFIVG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

  • With a Return On Assets value of 1.48%, IVG is not doing good in the industry: 63.72% of the companies in the same industry are doing better.
  • IVG has a better Return On Equity (10.01%) than 66.37% of its industry peers.
  • IVG's Return On Invested Capital of 3.89% is on the low side compared to the rest of the industry. IVG is outperformed by 61.95% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for IVG is below the industry average of 8.85%.
Industry RankSector Rank
ROA 1.48%
ROE 10.01%
ROIC 3.89%
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
IVG.MI Yearly ROA, ROE, ROICIVG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • Looking at the Profit Margin, with a value of 1.82%, IVG is doing worse than 63.72% of the companies in the same industry.
  • In the last couple of years the Profit Margin of IVG has grown nicely.
  • With a Operating Margin value of 4.33%, IVG is not doing good in the industry: 61.06% of the companies in the same industry are doing better.
  • In the last couple of years the Operating Margin of IVG has grown nicely.
  • With a Gross Margin value of 16.00%, IVG is not doing good in the industry: 92.04% of the companies in the same industry are doing better.
  • IVG's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.33%
PM (TTM) 1.82%
GM 16%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
IVG.MI Yearly Profit, Operating, Gross MarginsIVG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IVG is destroying value.
  • The number of shares outstanding for IVG has been reduced compared to 1 year ago.
  • The number of shares outstanding for IVG has been increased compared to 5 years ago.
  • Compared to 1 year ago, IVG has an improved debt to assets ratio.
IVG.MI Yearly Shares OutstandingIVG.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
IVG.MI Yearly Total Debt VS Total AssetsIVG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 1.74, we must say that IVG is in the distress zone and has some risk of bankruptcy.
  • IVG has a Altman-Z score (1.74) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of IVG is 9.94, which is on the high side as it means it would take IVG, 9.94 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 9.94, IVG is not doing good in the industry: 61.95% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 1.29 is on the high side and indicates that IVG has dependencies on debt financing.
  • IVG has a worse Debt to Equity ratio (1.29) than 84.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF 9.94
Altman-Z 1.74
ROIC/WACC0.52
WACC7.56%
IVG.MI Yearly LT Debt VS Equity VS FCFIVG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

  • IVG has a Current Ratio of 1.91. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
  • IVG has a Current ratio of 1.91. This is in the better half of the industry: IVG outperforms 66.37% of its industry peers.
  • IVG has a Quick Ratio of 1.38. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
  • IVG's Quick ratio of 1.38 is fine compared to the rest of the industry. IVG outperforms 75.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.38
IVG.MI Yearly Current Assets VS Current LiabilitesIVG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • IVG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.43%.
  • IVG shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.82% yearly.
  • The Revenue has decreased by -7.24% in the past year.
  • IVG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.06% yearly.
EPS 1Y (TTM)-23.43%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-61.54%
Revenue 1Y (TTM)-7.24%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-9.61%

3.2 Future

  • Based on estimates for the next years, IVG will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.81% on average per year.
  • Based on estimates for the next years, IVG will show a small growth in Revenue. The Revenue will grow by 4.30% on average per year.
EPS Next Y-25.28%
EPS Next 2Y1.11%
EPS Next 3Y8.02%
EPS Next 5Y10.81%
Revenue Next Year-5.37%
Revenue Next 2Y0.91%
Revenue Next 3Y2.67%
Revenue Next 5Y4.3%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
IVG.MI Yearly Revenue VS EstimatesIVG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
IVG.MI Yearly EPS VS EstimatesIVG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 14.09, the valuation of IVG can be described as correct.
  • Based on the Price/Earnings ratio, IVG is valued cheaper than 84.96% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.68. IVG is valued slightly cheaper when compared to this.
  • The Price/Forward Earnings ratio is 8.88, which indicates a very decent valuation of IVG.
  • Based on the Price/Forward Earnings ratio, IVG is valued cheaper than 89.38% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of IVG to the average of the S&P500 Index (28.06), we can say IVG is valued rather cheaply.
Industry RankSector Rank
PE 14.09
Fwd PE 8.88
IVG.MI Price Earnings VS Forward Price EarningsIVG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IVG indicates a somewhat cheap valuation: IVG is cheaper than 74.34% of the companies listed in the same industry.
  • 78.76% of the companies in the same industry are more expensive than IVG, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.71
EV/EBITDA 6.37
IVG.MI Per share dataIVG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.43
EPS Next 2Y1.11%
EPS Next 3Y8.02%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • IVG has a Yearly Dividend Yield of 1.75%.
  • IVG's Dividend Yield is a higher than the industry average which is at 1.43.
  • IVG's Dividend Yield is comparable with the S&P500 average which is at 1.84.
Industry RankSector Rank
Dividend Yield 1.75%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 33.46% of the earnings are spent on dividend by IVG. This is a low number and sustainable payout ratio.
DP33.46%
EPS Next 2Y1.11%
EPS Next 3Y8.02%
IVG.MI Yearly Income VS Free CF VS DividendIVG.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M
IVG.MI Dividend Payout.IVG.MI Dividend Payout, showing the Payout Ratio.IVG.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

IVECO GROUP NV

BIT:IVG (2/13/2026, 7:00:00 PM)

18.875

+0.02 (+0.13%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-12
Earnings (Next)05-07
Inst Owners33.94%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap5.12B
Revenue(TTM)14.48B
Net Income(TTM)263.00M
Analysts70.77
Price Target20.11 (6.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.75%
Yearly Dividend0.27
Dividend Growth(5Y)N/A
DP33.46%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-42.41%
Min EPS beat(2)-69.38%
Max EPS beat(2)-15.44%
EPS beat(4)2
Avg EPS beat(4)-3.86%
Min EPS beat(4)-69.38%
Max EPS beat(4)63.53%
EPS beat(8)5
Avg EPS beat(8)11.85%
EPS beat(12)7
Avg EPS beat(12)5.5%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.89%
Min Revenue beat(2)-10.33%
Max Revenue beat(2)8.56%
Revenue beat(4)2
Avg Revenue beat(4)-0.65%
Min Revenue beat(4)-10.33%
Max Revenue beat(4)9.28%
Revenue beat(8)5
Avg Revenue beat(8)0.3%
Revenue beat(12)6
Avg Revenue beat(12)0.64%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-19.08%
EPS NY rev (1m)-3.77%
EPS NY rev (3m)-14.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.88%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.12%
Valuation
Industry RankSector Rank
PE 14.09
Fwd PE 8.88
P/S 0.35
P/FCF 8.71
P/OCF 3.61
P/B 1.95
P/tB 7.86
EV/EBITDA 6.37
EPS(TTM)1.34
EY7.1%
EPS(NY)2.13
Fwd EY11.27%
FCF(TTM)2.17
FCFY11.49%
OCF(TTM)5.23
OCFY27.72%
SpS53.38
BVpS9.69
TBVpS2.4
PEG (NY)N/A
PEG (5Y)0.43
Graham Number17.09
Profitability
Industry RankSector Rank
ROA 1.48%
ROE 10.01%
ROCE 5.15%
ROIC 3.89%
ROICexc 4.75%
ROICexgc 5.91%
OM 4.33%
PM (TTM) 1.82%
GM 16%
FCFM 4.06%
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
ROICexc(3y)4.85%
ROICexc(5y)N/A
ROICexgc(3y)5.77%
ROICexgc(5y)N/A
ROCE(3y)5.17%
ROCE(5y)N/A
ROICexgc growth 3Y26.65%
ROICexgc growth 5Y12.05%
ROICexc growth 3Y25.45%
ROICexc growth 5Y11.07%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
F-Score5
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF 9.94
Debt/EBITDA 2.49
Cap/Depr 112.3%
Cap/Sales 5.74%
Interest Coverage 250
Cash Conversion 103.8%
Profit Quality 223.57%
Current Ratio 1.91
Quick Ratio 1.38
Altman-Z 1.74
F-Score5
WACC7.56%
ROIC/WACC0.52
Cap/Depr(3y)146.94%
Cap/Depr(5y)121.88%
Cap/Sales(3y)5.9%
Cap/Sales(5y)5.2%
Profit Quality(3y)212.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.43%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-61.54%
EPS Next Y-25.28%
EPS Next 2Y1.11%
EPS Next 3Y8.02%
EPS Next 5Y10.81%
Revenue 1Y (TTM)-7.24%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-9.61%
Revenue Next Year-5.37%
Revenue Next 2Y0.91%
Revenue Next 3Y2.67%
Revenue Next 5Y4.3%
EBIT growth 1Y-33.08%
EBIT growth 3Y38.23%
EBIT growth 5Y15.55%
EBIT Next Year64.49%
EBIT Next 3Y27.62%
EBIT Next 5YN/A
FCF growth 1Y143.98%
FCF growth 3YN/A
FCF growth 5Y-8.52%
OCF growth 1Y26.36%
OCF growth 3Y26.42%
OCF growth 5Y8.96%

IVECO GROUP NV / IVG.MI FAQ

Can you provide the ChartMill fundamental rating for IVECO GROUP NV?

ChartMill assigns a fundamental rating of 4 / 10 to IVG.MI.


What is the valuation status for IVG stock?

ChartMill assigns a valuation rating of 6 / 10 to IVECO GROUP NV (IVG.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for IVECO GROUP NV?

IVECO GROUP NV (IVG.MI) has a profitability rating of 5 / 10.


How financially healthy is IVECO GROUP NV?

The financial health rating of IVECO GROUP NV (IVG.MI) is 3 / 10.


Can you provide the expected EPS growth for IVG stock?

The Earnings per Share (EPS) of IVECO GROUP NV (IVG.MI) is expected to decline by -25.28% in the next year.